Inari Medical, Inc.

Equities

NARI

US45332Y1091

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 01:30:00 18/07/2024 am IST			5-day change	1st Jan Change
58.62 ^USD	+1.10%		+13.43%	-9.70%

16/07	Truist Raises Price Target on Inari Medical to $60 From $47, Maintains Hold Rating	MT
15/07	Morgan Stanley Raises Price Target on Inari Medical to $60 From $55, Keeps Overweight Rating	MT

Inari Medical, Inc. Provides Revenue Guidance for the Fourth Quarter of 2020

January 13, 2021 at 06:30 pm IST

Inari Medical, Inc. provided revenue guidance for the fourth quarter of 2020. For the quarter, preliminary unaudited revenue is expected to be in the range of $47.9 million to $48.9 million in the fourth quarter of 2020.

Latest news about Inari Medical, Inc.

Truist Raises Price Target on Inari Medical to $60 From $47, Maintains Hold Rating	16/07	MT
Morgan Stanley Raises Price Target on Inari Medical to $60 From $55, Keeps Overweight Rating	15/07	MT
Inari Medical, Inc.(NasdaqGS:NARI) dropped from Russell 3000E Value Index	01/07	CI
Inari Medical, Inc.(NasdaqGS:NARI) dropped from Russell 3000 Value Index	01/07	CI
Inari Medical, Inc.(NasdaqGS:NARI) dropped from Russell 2500 Value Index	01/07	CI
Inari Medical, Inc.(NasdaqGS:NARI) dropped from Russell Small Cap Comp Value Index	01/07	CI
Inari Medical, Inc.(NasdaqGS:NARI) dropped from Russell 2000 Value Index	01/07	CI
Inari Medical Insider Sold Shares Worth $1,741,579, According to a Recent SEC Filing	21/06	MT
Sector Update: Health Care Stocks Lower Thursday Afternoon	24/05	MT
Inari Medical Sues Imperative Care, Truvic Medical for Alleged Patent Infringement	24/05	MT
Inari Medical Sues Imperative Care, Truvic Medical for Alleged Patent Infringement	23/05	MT
Inari Medical Insider Sold Shares Worth $1,863,977, According to a Recent SEC Filing	20/05	MT
Transcript : Inari Medical, Inc. Presents at Bank of America Health Care Conference 2024, May-15-2024 11:20 AM	15/05
Inari Medical Insider Sold Shares Worth $1,619,047, According to a Recent SEC Filing	04/05	MT
Inari Medical Shares Jump on Higher Q1 Revenue	01/05	MT
Transcript : Inari Medical, Inc., Q1 2024 Earnings Call, Apr 30, 2024	01/05
Earnings Flash (NARI) INARI MEDICAL Reports Q1 Revenue $143.2M, vs. Street Est of $137.8M	01/05	MT
Inari Medical, Inc. Provides Earnings Guidance for the Full Year 2024	01/05	CI
Inari Medical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	01/05	CI
Inari Medical, Inc. Appoints Tim Benner as Senior Vice President of U.S. Sales	03/04	CI
Inari Medical, Inc.(NasdaqGS:NARI) added to S&P 600 Health Care	01/04	CI
Inari Medical, Inc.(NasdaqGS:NARI) added to S&P 600	01/04	CI
Inari Medical, Inc.(NasdaqGS:NARI) dropped from S&P 400 Health Care	01/04	CI
Inari Medical, Inc.(NasdaqGS:NARI) dropped from S&P 400	01/04	CI
Sector Update: Financial Stocks Gain Late Afternoon	27/03	MT

Chart Inari Medical, Inc.

Duration

Period

More charts

Company Profile

Inari Medical, Inc. is a medical device company. The Companyâs products primarily consist of ClotTriever and FlowTriever systems, which are catheter-based mechanical thrombectomy systems that are used for the treatment of the venous thromboembolism (VTE) deep vein thrombosis (DVT), and pulmonary embolism (PE). Its InThrill system is used for the removal of emboli and thrombi from the peripheral vasculature. The LimFlow system is indicated for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and are at risk of major amputation. It also offers RevCore thrombectomy catheter, which is a thrombectomy device for venous stent thrombosis, Triever 16 Curve catheter, which is used for venous thrombus removal, and ClotTriever Bold catheter, which is used for DVT and the removal of acute and chronic clots in the peripheral vasculature. Its ClotTriever XL, which is a catheter for efficient clot removal with minimal blood loss.

Sector

Medical Equipment, Supplies & Distribution

Calendar

30/07/2024 - Q2 2024 Earnings Release

Related indices

Russell 2000

More about the company

Income Statement Evolution

More financial data

Ratings for Inari Medical, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

58.62 USD

Average target price

66 USD

Spread / Average Target

+12.59%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Equipment

	1st Jan change	Capi.
INARI MEDICAL, INC.	-9.70%	3.37B
SHOCKWAVE MEDICAL	+75.69%	12.57B
PENUMBRA, INC.	-19.21%	7.63B
MASIMO CORPORATION	-7.03%	5.84B
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.	+10.32%	5.16B
GETINGE AB	-16.50%	4.75B
ASAHI INTECC CO., LTD.	-12.15%	4.17B
APT MEDICAL INC.	+17.06%	4.16B
NOVOCURE LIMITED	+28.00%	2.07B
SKAN GROUP AG	-2.97%	1.99B

Medical Equipment